Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

FREDERICK SMITH

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1730185935
CMS profile
124323
Location
CHEVY CHASE, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$9,408.25

187 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme LLC $4,700.04 9
Novartis Pharmaceuticals Corporation $474.34 13
AstraZeneca Pharmaceuticals LP $387.42 15
E.R. Squibb & Sons, L.L.C. $237.29 11
Janssen Biotech, Inc. $220.55 8
Astellas Pharma US Inc $212.28 8
Takeda Pharmaceuticals U.S.A., Inc. $205.29 8
Ipsen Biopharmaceuticals, Inc $194.10 5
Daiichi Sankyo Inc. $168.42 8
Incyte Corporation $133.17 6
Bayer Healthcare Pharmaceuticals Inc. $129.71 5
Genentech USA, Inc. $128.37 5
Adaptive Biotechnologies Corporation $124.63 3
Eisai Inc. $118.71 5
Lilly USA, LLC $102.39 5
PFIZER INC. $102.29 3
ABBVIE INC. $98.64 4
GENZYME CORPORATION $97.97 3
PharmaEssentia USA Corporation $96.36 3
Rigel Pharmaceuticals, Inc. $92.75 3
ARRAY BIOPHARMA INC $90.41 3
Coherus Biosciences Inc. $87.69 3
Pharmacosmos Therapeutics Inc. $85.45 4
Gilead Sciences, Inc. $85.27 4
Regeneron Healthcare Solutions, Inc. $75.74 3
Kite Pharma, Inc. $71.60 3
Blueprint Medicines Corporation $68.16 2
BeiGene USA, Inc. $67.88 3
Myriad Genetic Laboratories, Inc. $64.96 3
Acrotech Biopharma Inc. $62.92 3
Celgene Corporation $59.49 3
Stemline Therapeutics Inc. $54.23 2
Spectrum Pharmaceuticals Inc. $47.12 2
PUMA BIOTECHNOLOGY, INC. $45.84 2
Exelixis Inc. $36.90 2
Karyopharm Therapeutics Inc. $34.76 1
TerSera Therapeutics LLC $32.74 1
Boehringer Ingelheim Pharmaceuticals, Inc. $32.04 1
Genmab U.S., Inc. $30.75 1
GlaxoSmithKline, LLC. $28.86 1
ADC Therapeutics America, Inc. $26.34 1
Janssen Pharmaceuticals, Inc $25.20 1
MorphoSys, US Inc. $24.68 1
Aveo Pharmaceuticals, Inc. $24.54 1
Kyowa Kirin, Inc. $24.13 1
Mirati Therapeutics, Inc. $23.42 1
Alexion Pharmaceuticals, Inc. $21.60 1
SpringWorks Therapeutics, Inc. $19.49 1
EMD Serono, Inc. $17.66 1
RECORDATI_RARE_DISEASES_INC. $13.66 1

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

187 matching records · $9,408.25 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 187 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 187.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Astellas Pharma US Inc $31.0512/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139446948 CMS
GENZYME CORPORATION $36.4712/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139568317 CMS
Myriad Genetic Laboratories, Inc. $17.3212/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261152540399 CMS
AstraZeneca Pharmaceuticals LP $22.6312/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105781504 CMS
AstraZeneca Pharmaceuticals LP $22.8412/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105452407 CMS
Ipsen Biopharmaceuticals, Inc $99.9912/10/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/20261091959425 CMS
Novartis Pharmaceuticals Corporation $99.7012/10/2024 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087240465 CMS
PFIZER INC. $32.1912/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131091101 CMS
TerSera Therapeutics LLC $32.7412/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261144714479 CMS
Lilly USA, LLC $17.8612/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261134981168 CMS
Genentech USA, Inc. $27.2612/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133012615 CMS
PharmaEssentia USA Corporation $30.2712/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261137306071 CMS
Astellas Pharma US Inc $23.9212/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139444704 CMS
Novartis Pharmaceuticals Corporation $30.2611/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087240463 CMS
BeiGene USA, Inc. $18.0411/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120844158 CMS
AstraZeneca Pharmaceuticals LP $28.4111/21/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261155838384 CMS
Exelixis Inc. $16.3811/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261138557932 CMS
Rigel Pharmaceuticals, Inc. $27.9711/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261145208431 CMS
Janssen Biotech, Inc. $23.8411/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078717498 CMS
ABBVIE INC. $28.2511/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261106123440 CMS
Daiichi Sankyo Inc. $20.0211/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089484616 CMS
Novartis Pharmaceuticals Corporation $99.7011/14/2024 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087240455 CMS
Blueprint Medicines Corporation $44.0311/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261147443384 CMS
Celgene Corporation $18.1311/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101176390 CMS
Janssen Biotech, Inc. $26.7211/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078717295 CMS
Merck Sharp & Dohme LLC $150.0011/08/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141761567 CMS
Merck Sharp & Dohme LLC $4,270.0011/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141892672 CMS
Takeda Pharmaceuticals U.S.A., Inc. $29.8611/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261144967950 CMS
Eisai Inc. $27.8011/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110746006 CMS
ARRAY BIOPHARMA INC $21.2311/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131265269 CMS
AstraZeneca Pharmaceuticals LP $25.8710/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105447225 CMS
Novartis Pharmaceuticals Corporation $10.2310/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087240457 CMS
Adaptive Biotechnologies Corporation $33.5510/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261150260590 CMS
E.R. Squibb & Sons, L.L.C. $10.2910/29/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101711373 CMS
Celgene Corporation $24.7210/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101176386 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $32.0410/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118130843 CMS
Mirati Therapeutics, Inc. $23.4210/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261117175544 CMS
Janssen Biotech, Inc. $34.6810/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078716415 CMS
Novartis Pharmaceuticals Corporation $33.3910/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087240459 CMS
PUMA BIOTECHNOLOGY, INC. $22.7710/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261113860646 CMS
AstraZeneca Pharmaceuticals LP $29.8010/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104253127 CMS
Daiichi Sankyo Inc. $28.3110/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089484608 CMS
Merck Sharp & Dohme LLC $98.5510/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141761569 CMS
Kite Pharma, Inc. $23.6710/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261128610377 CMS
Bayer Healthcare Pharmaceuticals Inc. $26.8710/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086165668 CMS
Coherus Biosciences Inc. $36.1910/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261147275616 CMS
Lilly USA, LLC $22.3010/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261134998944 CMS
Novartis Pharmaceuticals Corporation $14.1310/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087240453 CMS
Spectrum Pharmaceuticals Inc. $22.4410/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261150655334 CMS
Astellas Pharma US Inc $26.6610/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139415143 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $26,535.02 287
PY2020 $11,469.96 210
PY2021 $19,775.99 229
PY2022 $65,599.66 258
PY2023 $18,155.50 212
PY2024 $9,408.25 187
PY2025 $7,753.89 198

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
FREDERICK SMITH, NPI 1730185935. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1730185935.
APA 7
IndustryPayments. (2026). FREDERICK SMITH, NPI 1730185935 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1730185935
Bluebook
FREDERICK SMITH, NPI 1730185935, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1730185935.

Source: Centers for Medicare & Medicaid Services, Open Payments.